Disentangling epitope spacing and antibody flexibility from avidity: A quantitative model for competition and bivalency in biosensor assays
Biophysical Journal · 2026-07 · 125 (13) · 3214-3228
DOI: 10.1016/j.bpj.2026.04.025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biophysical Journal, 2026-07. Verfasst von Nathalie Wyss und 6 weiteren Autor:innen. Beteiligte Einrichtung: Novo Nordisk A/S, 2760 Måløv, Denmark; Department of Molecular Biology & Genetics, Aarhus University, 8000 Aarhus C, Denmark. Hauptthemen laut MEDLINE: Epitopes, Antibody Affinity, Biosensing Techniques, Antibodies. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Innovation Fund Denmark.
Abstract (Originalsprache)
Multivalent binding of antibodies is boosted by avidity, a phenomenon that manifests as an increase in binding strength when an interaction occurs via several binding sites. Avidity in antibodies is typically measured using biosensor experiments such as surface plasmon resonance (SPR). However, the key step in formation of the closed, bivalent complex is optically silent, and currently no general methods can deconvolute the microscopic equilibrium constants that govern avidity. Here, we study antibody avidity binding to nanocalipers based on protein origami that place epitopes at well-controlled distances from 8 to 22 nm apart. We describe a new, improved bivalent model that accounts for the competition between bivalent 1:1 and 2:1 (antibody:antigen) complexes, thereby generating a comprehensive, robust, and fast model algorithm to fit avidity in SPR measurements. We use this to map the distance-dependent avidity enhancement of antibodies sampling a range of flexibilities and describe the underlying microstates populated during bivalent binding. With the improved model, we studied avidity at different epitope spacings and found a rather flat distance dependence in avidity for different epitope spacings. Our findings will improve the current workflow of quantifying avidity with SPR and can serve as a tool to achieve a more detailed insight into the mechanistic basis of bivalent binding in antibodies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Novo Nordisk A/S, 2760 Måløv, Denmark; Department of Molecular Biology & Genetics, Aarhus University, 8000 Aarhus C, Denmark.
- Novo Nordisk A/S, 2760 Måløv, Denmark.
- Novo Nordisk A/S, 2760 Måløv, Denmark. Electronic address: cwib@novonordisk.com.
- Department of Molecular Biology & Genetics, Aarhus University, 8000 Aarhus C, Denmark. Electronic address: magnus@mbg.au.dk.
Förderung
- Innovation Fund Denmark
Zitieren
APA
Wyss, N., Riis, C., Karkov, H. S., Lund, S., Ferkinghoff-Borg, J., Wiberg, C., & Kjaergaard, M. (2026). Disentangling epitope spacing and antibody flexibility from avidity: A quantitative model for competition and bivalency in biosensor assays. Biophysical Journal, 125(13), 3214-3228. https://doi.org/10.1016/j.bpj.2026.04.025
Vancouver
Wyss N, Riis C, Karkov HS, Lund S, Ferkinghoff-Borg J, Wiberg C, et al. Disentangling epitope spacing and antibody flexibility from avidity: A quantitative model for competition and bivalency in biosensor assays. Biophysical Journal. 2026;125(13):3214-3228. doi:10.1016/j.bpj.2026.04.025
BibTeX
@article{Wyss2026,
author = {Wyss, Nathalie and Riis, Christoffer and Karkov, Hanne Sophie and Lund, Søren and Ferkinghoff-Borg, Jesper and Wiberg, Charlotte and Kjaergaard, Magnus},
title = {Disentangling epitope spacing and antibody flexibility from avidity: A quantitative model for competition and bivalency in biosensor assays},
journal = {Biophysical Journal},
year = {2026},
volume = {125},
number = {13},
pages = {3214--3228},
doi = {10.1016/j.bpj.2026.04.025}
}
EUVIMED